Katarina
Katarina Cuk, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20150197812 | CIRCULATING miRNAs AS MARKERS FOR BREAST CANCER - The present invention is directed to methods for diagnosing breast cancer, metastasizing breast cancer, or for determining the CTC status in a subject. Moreover, the present invention is concerned with devices and kits for carrying methods of the invention. The methods comprise determining in a sample of a subject suspected to be afflicted with breast cancer the amount of at least one miRNA selected from a recited list of miRNAs, followed by comparing the amount with one or more references, whereby breast cancer is to be diagnosed. | 07-16-2015 |
Katarina Drakenberg, Lindingo SE
Patent application number | Description | Published |
---|---|---|
20090162373 | MATERIALS AND METHODS FOR TREATMENT OF HEPATITIS C - The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Furthermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention. | 06-25-2009 |
Katarina Edsman, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20140039061 | HYALURONIC ACID COMPOSITION - An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G′ of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and a method of manufacturing such a composition. | 02-06-2014 |
Katarina Emanuelsson, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20100136598 | NOVEL MESENCHYMAL PROGENITOR CELLS DERIVED FROM HUMAN BLASTOCYST-DERIVED STEM CELLS - Described herein is a mesenchymal human progenitor (hBS-MP) cell population derived from human blastocyst-derived stem (hBS) cells and a method to obtain the progenitor cell population in which is eliminated the need of co-culture steps, cell sorting, manual selection, and transfections. Also, the use of the hBS-MP cells in drug discovery and specifically for toxicity testings as well as for therapeutic use is made possible. | 06-03-2010 |
Katarina Eriksson, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20150329257 | PACKAGE OF A STACK OF FLEXIBLE ARTICLES - A package with a stack of flexible articles includes a stack of flexible articles, a flexible outer cover, having a first end side panel and a second end side panel opposing the first end side panel. The package further includes two and preferably only two stiffening elements that are stiffer than the flexible outer cover and the flexible articles, whereby one of the stiffening elements is positioned against the interior surface of the end side panels of the outer cover and the other stiffening element is positioned against the opposing end side panel of the outer cover. | 11-19-2015 |
Katarina Faernegardh, Ekeroe SE
Patent application number | Description | Published |
---|---|---|
20150025068 | BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER - A compound of formula (I), useful for the treatment of cancer, inflammation and inflammatory disorders, and a pharmaceutical composition containing the compound. | 01-22-2015 |
Katarina Farnegardh, Ekero SE
Patent application number | Description | Published |
---|---|---|
20130172339 | SULFONAMIDE COMPOUNDS - A compound of formula (I), wherein A is S, O or a double bond, and L is a substituted thiazolyl, phenyl or pyridyl. The compound is useful for the treatment of inflammation and cancer. | 07-04-2013 |
Katarina Flodstrom, Solna SE
Patent application number | Description | Published |
---|---|---|
20110236713 | FUNCTIONALLY GRADED MATERIAL SHAPE AND METHOD FOR PRODUCING SUCH A SHAPE - The invention relates to a functionally graded material shape ( | 09-29-2011 |
Katarina Flodstrom, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20110260368 | METHOD FOR MANUFACTURING CERAMIC COMPONENTS - The invention concerns a method for manufacturing a ceramic material with pseudo-isotropic microstructure. The method for tailoring the microstructure for manufacturing of sintered ceramic components involves a spark plasma sintering (SPS) process. By performing the SPS process in at least two steps it is possible to separate densification from grain growth. An initial sintering step at a first temperature and a first pressure, followed by a controlled grain growth step at a higher temperature and lower pressure makes it possible to manufacture ceramic components with controlled microstructure and improved mechanical properties. | 10-27-2011 |
20110266719 | LARGE CERAMIC COMPONENT AND METHOD OF MANUFACTURE - The invention concerns a sintered ceramic component of silicon nitride or sialon suitable as rolling element in a bearing and a manufacturing method for making such ceramic components. The ceramic component has high density and a homogeneous and fine microstructure, giving the component excellent mechanical properties. Manufacturing of the sintered ceramic component by SPS is cost-effective and rapid. | 11-03-2011 |
Katarina Flodström, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20110125277 | DUAL-SIDED JOINT IMPLANT HAVING A WEAR RESISTANT SURFACE AND A BIOACTIVE SURFACE - A medical implant for application in an articulating surface of a joint, comprising a plate-shaped structure having a first surface and a second surface facing mutually opposite directions, the first surface comprising a first biocompatible metal, metal alloy or ceramic and being devised to form a wear resistant articulate surface configured to face the articulating part of the joint; and the second surface comprising a bioactive ceramic or bioactive glass incorporated into a second metal, metal alloy or ceramic and being devised to form a bone contacting surface configured to face bone structure in the joint; wherein: the first surface and the second surface are adhered by means of a sintered material structure. Possibly the second surface is a sintered mixture having a homogenous microstructure comprising the bioactive ceramic or bioactive glass and the second metal, metal alloy or ceramic. | 05-26-2011 |
Katarina Frej, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20100129906 | Method for Obtaining Xeno-Free Hbs Cell line - A method for obtaining a stable xeno-free hBS cell line, xeno-free hBS cell lines obtained according to said method and use thereof. The method comprises the steps of: | 05-27-2010 |
Katarina Haakansson, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20130330360 | ANTAGONISTIC DR3 LIGANDS - The present disclosure relates to treatment of inflammatory diseases. In particular, the present disclosure relates to antagonistic DR | 12-12-2013 |
20130336984 | ANTAGONISTIC DR3 LIGANDS - The present invention relates to treatment of inflammatory diseases. In particular, the present invention relates to antagonistic DR3 ligands useful for treating inflammatory diseases. | 12-19-2013 |
20140294853 | ANTAGONISTIC DR3 LIGANDS - The present invention relates to treatment of inflammatory diseases. In particular, the present invention relates to antagonistic DR3 ligands useful for treating inflammatory diseases. | 10-02-2014 |
Katarina Hansen, Kerteminde DK
Patent application number | Description | Published |
---|---|---|
20150122795 | Medical Device for Preparing Thermoplastic Material - A device for preparing a thermoplastic material, with dry heat, for use in patient fixation. The device generates circulated heat to a threshold temperature. Once the thermoplastic material has become pliable, it is molded into a cast for fixation purposes. The circulated heat may be generated by a device having a housing and a support member movably attached to the housing. The device also includes a heating element and an array of circulation elements. | 05-07-2015 |
Katarina Kolostova, Nitra SK
Patent application number | Description | Published |
---|---|---|
20160122704 | METHOD FOR SEPARATION OF SPORADIC CELLS FROM BODY FLUIDS, AND APPARATUS FOR CARRYING OUT SAID METHOD - Method for gentle separation of viable sporadic cells from body fluids such as blood, from malignant effusions, bronchoalveolar lavage fluid, peritoneal lavage fluid and amniotic fluid, based on a filter membrane which is in an intimate contact with an absorbent material. Using the present method it is possible to isolate for example circulating and disseminated tumor cells, endometrial cells and circulating trophoblast cells, allowing subsequent detection, quantification, characterization and especially culturing of said cells. An apparatus for carrying out the method is further disclosed. | 05-05-2016 |
Katarina Loweberg, Akersberga SE
Patent application number | Description | Published |
---|---|---|
20150294301 | METHOD FOR PURCHASING A PRODUCT USING A PORTABLE COMMUNICATION DEVICE - Method for purchasing a product using a portable communication device ( | 10-15-2015 |
20150302391 | METHOD FOR MAKING A PAYMENT USING A PORTABLE COMMUNICATION DEVICE - Method for making a payment using a portable communication device ( | 10-22-2015 |
Katarina Lukacsy, Galway IE
Patent application number | Description | Published |
---|---|---|
20150200879 | Topic Categorized Instant Message Communication - Techniques are presented for defining, for an online conference session, a plurality of pages, which may be preconfigured, based on information received from a moderating participant having administrative privileges for the conference session, each page corresponding to a discussion topic of a text-based conversation. A request is received from the moderating participant to select one of the plurality of pages. After a page has been selected, the selected page is synchronized such that the selected page is displayed to the moderating participant and each of the one or more other participants, and subsequent text-based communications are displayed in the display area of the selected page. | 07-16-2015 |
Katarina Matusikova, Athlone IE
Patent application number | Description | Published |
---|---|---|
20100175054 | SYSTEM AND METHOD FOR TRANSFORMING A UML MODEL INTO AN OWL REPRESENTATION - A system and method for transforming a human-readable Unified Mark-Up Language (UML) model having a plurality of packages for design purposes into a machine-readable Web Ontology Language (OWL) representation having a plurality of OWL namespaces or a plurality of OWL documents for controlling network elements in a telecommunications network. A processor translates the human-readable UML model into one or more machine-readable OWL ontologies. In one embodiment, the processor produces one ontology (one file) with several namespaces. Thus, the translated ontology corresponds to the UML model, and each UML package in the UML model corresponds to a namespace. In another embodiment, the processor produces several ontologies (several files) corresponding to the UML packages in the UML model, wherein each ontology has just one namespace for its elements. The UML model in this embodiment corresponds to a base ontology importing all created ontologies. | 07-08-2010 |
20110035202 | BEHAVIOUR MODEL FOR A COMMUNICATION NETWORK - The invention relates to a method for enabling generation of a behaviour model for at least a part of a communications network, which method utilizes a semantically rich ontology-based network model comprising an ontology of which instances represent different events/actions that may occur in the network, as well as probability information indicating the probabilistic correlation between said events/actions. The method comprises the step of creating, in a semantic ontology-based modelling language, a modelling entity having at least three properties of which: a first property is a reference to a first instance of said network model ontology, which first instance hence represents a first event/action; a second property is a reference to a second instance of said network model ontology, which second instance hence represents a second event/action; and a third property is a numerical value based on said probability information and representing the probability of said second event/action occurring given said first event/action. | 02-10-2011 |
Katarina Mulinkova, Valaska Bela SI
Patent application number | Description | Published |
---|---|---|
20090305406 | Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method - The invention relates to a novel method of cultivation of mesenchymal stem cells, wherein after aseptic separation of mononuclear cells from the marrow blood, said cells are seeded in low density into sterile plastic cultivation vessels and cultivated for approximately one to three weeks in CellGro™ Hematopoietic Stem Cell Medium, certified for the clinical use, with an addition of 10% human serum and supplements, wherein the supplements are added at least once in the course of the cultivation, without removal of hematopoietic cells and without medium exchange during the cultivation procedure, without any interference with the closed cultivation system, under the standard conditions for the cultivation of tissue cultures. | 12-10-2009 |
Katarina Pavlikova, Port Moody CA
Patent application number | Description | Published |
---|---|---|
20110248929 | ELECTRONIC DEVICE AND METHOD OF CONTROLLING SAME - A method includes detecting a touch at a touch location on a touch-sensitive display, identifying a delay associated with the touch location, and when a force value related to the touch meets a first threshold value, providing a first tactile feedback after waiting the delay. | 10-13-2011 |
20110279380 | METHOD OF PROVIDING TACTILE FEEDBACK AND ELECTRONIC DEVICE - A method includes detecting, at a first time, a first touch associated with a first touch value that meets one of a first touch threshold and a second touch threshold, detecting, at a second time, a second touch associated with a second touch value that meets one of the first touch threshold and the second touch threshold, providing first tactile feedback at the first time, and providing second tactile feedback at the second time when the time period between the first time and the second time meets a time threshold. | 11-17-2011 |
20110279381 | METHOD OF PROVIDING TACTILE FEEDBACK AND ELECTRONIC DEVICE - A method includes detecting a touch on a touch-sensitive display, determining when a touch value associated with the touch meets a first touch threshold, determining a first period of time between detecting the touch and when the touch value meets the first touch threshold, and providing a first tactile feedback when the first period of time is meets a first time threshold. | 11-17-2011 |
Katarina Radosevic, Nootdorp NL
Patent application number | Description | Published |
---|---|---|
20130216580 | HETEROLOGOUS PRIME BOOST VACCINATION REGIMEN AGAINST MALARIA - Described are methods for inducing an immune response in a subject against an antigen from a malaria-causing parasite, preferably | 08-22-2013 |
20150196632 | VACCINE AGAINST RSV - Provided is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype | 07-16-2015 |
20150320854 | VACCINE AGAINST RSV - Described is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype that comprises polynucleotide encoding a RSV F protein or immunologically active part thereof. | 11-12-2015 |
Katarina Radosevic, Rotterdam NL
Patent application number | Description | Published |
---|---|---|
20090110695 | Compositions Comprising a Recombinant Adenovirus and an Adjuvant - The invention relates to pharmaceutical compositions comprising replication-defective adenoviruses, said adenoviruses generally comprising an adenoviral genome wherein a heterologous nucleic acid of interest is incorporated, and wherein said nucleic acid typically encodes an antigen. Such compositions are suitable for vaccination purposes. The pharmaceutical compositions of the present invention further comprise an adjuvant, which stimulates and increases the immune response towards the antigen encoded by the heterologous nucleic acid. Preferred adjuvants are oil-emulsion based adjuvants and aluminium-based adjuvants. | 04-30-2009 |
20090123438 | Multivalent Vaccines Comprising Recombinant Viral Vectors - The invention relates to vaccines comprising recombinant vectors, such as recombinant adenoviruses. The vectors comprise heterologous nucleic acids encoding for at least two antigens from one or more tuberculosis-causing bacilli. The invention also relates to the use of specific protease recognition sites linking antigens through which the encoded antigens are separated upon cleavage. After cleavage, the antigens contribute to the immune response in a separate manner. The recombinant vectors may comprise a nucleic acid encoding the protease cleaving the linkers and separating the antigens. The invention furthermore relates to the use of genetic adjuvants encoded by the recombinant vectors, wherein such genetic adjuvants may also be cleaved through the presence of the cleavable linkers and the specific protease. | 05-14-2009 |
20110256166 | Multivalent vaccines comprising recombinant viral vectors - The invention relates to vaccines comprising recombinant vectors, such as recombinant adenoviruses. The vectors comprise heterologous nucleic acids encoding for at least two antigens from one or more tuberculosis-causing bacilli. Also described is the use of specific protease recognition sites linking antigens through which the encoded antigens are separated upon cleavage. After cleavage, the antigens contribute to the immune response in a separate manner. The recombinant vectors may comprise a nucleic acid encoding the protease cleaving the linkers and separating the antigens. Further described is the use of genetic adjuvants encoded by the recombinant vectors, wherein such genetic adjuvants may also be cleaved through the presence of the cleavable linkers and the specific protease. | 10-20-2011 |
20110281347 | Multivalent vaccines comprising recombinant viral vectors - Described are vaccines comprising recombinant vectors, such as recombinant adenoviruses. The vectors comprise heterologous nucleic acids encoding at least two antigens from one or more tuberculosis-causing bacilli. Also described is the use of specific protease recognition sites linking antigens through which the encoded antigens are separated upon cleavage. After cleavage, the antigens contribute to the immune response in a separate manner. The recombinant vectors may comprise a nucleic acid encoding the protease cleaving the linkers and separating the antigens. Also described is the use of genetic adjuvants encoded by the recombinant vectors, wherein such genetic adjuvants may also be cleaved through the presence of the cleavable linkers and the specific protease. | 11-17-2011 |
Katarina Ranlund, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20090208562 | Vaccine Composition Comprising a Fibronectin Binding Protein or a Fibronectin Binding Peptide - The present invention relates to a composition comprising at least one fibronectin binding protein, and/or at least one a truncated fibronectin binding protein and/or at least one fibronectin binding peptide, all comprising at least one fibronectin binding domain; and at least one Iscom matrixcomplex and/or liposome and/or at least one lipid and at least one saponin, whereby the at least one lipid and the at least one saponin may be in complex, solution or suspension. Further, it regards use thereof for the production of a vaccine against a micro organism that comprises at least one one fibronectin binding domain. It also regards a kit of parts comprising at least two compartments, wherein one compartment comprises at least one truncated fibronectin binding protein and/or a fibronectin binding peptide, that comprises at least one fibronectin binding domain, and another compartment comprises an instruction for use and/or an Iscom matrixcomplex and/or an iscom complex and or a liposome. Further it relates to a method for vaccination of an individual. | 08-20-2009 |
20110303563 | VACCINE COMPOSITION COMPRISING A FIBRONECTIN BINDING PROTEIN OR A FIBRONECTIN BINDING PEPTIDE - The present invention relates to a composition comprising at least one fibronectin binding protein, and/or at least one a truncated fibronectin binding protein and/or at least one fibronectin binding peptide, all comprising at least one fibronectin binding domain; and at least one iscom matrix complex and/or liposome and/or at least one lipid and at least one saponin, whereby the at least one lipid and the at least one saponin may be in complex, solution or suspension. Further, it regards use thereof for the preparation of a vaccine against a micro organism that comprises at least one fibronectin binding domain. It also relates to a kit of parts comprising at least two compartments, wherein one compartment comprises at least one truncated fibronectin binding protein and/or a fibronectin binding peptide, that comprises at least one fibronectin binding domain, and another compartment comprises an instruction for use and/or an iscom matrix complex and/or an iscom complex and or a liposome. Further it relates to a method for vaccination of an individual. | 12-15-2011 |
20140335049 | QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF - Fraction A of Quil A can be used together with at least one other adjuvant for the preparation of an adjuvant composition, where the included adjuvant components act synergistically to enhance level of immune response and have synergistic immunomodulating activity on the co-administered antigens or immunogens. Other adjuvants can comprise saponins, naturally occurring, synthetic or semisynthetic saponin molecules; e.g. saponins and saponin fractions from Quil A, cell wall skeleton, block polymers, TDM, lipopeptides, LPS and LPS-derivatives, Lipid A from different bacterial species and derivatives thereof, e.g., monophosphoryl lipid A, CpG variants, CT and LT or fractions thereof. | 11-13-2014 |
20150320858 | QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF - Fraction A of Quil A can be used together with at least one other adjuvant for the preparation of an adjuvant composition, where the included adjuvant components act synergistically to enhance level of immune response and have synergistic immunomodulating activity on the co-administered antigens or immunogens. Other adjuvants can comprise saponins, naturally occurring, synthetic or semisynthetic saponin molecules; e.g. saponins and saponin fractions from Quil A, cell wall skeleton, block polymers, TDM, lipopeptides, LPS and LPS-derivatives, Lipid A from different bacterial species and derivatives thereof, e.g., monophosphoryl lipid A, CpG variants, CT and LT or fractions thereof. | 11-12-2015 |
Katarina Rot, Linz AT
Patent application number | Description | Published |
---|---|---|
20090099323 | Melamine-formaldehyde resin solution and process for producing the same - A melamine-formaldehyde resin solution having a formaldehyde/melamine ratio smaller than or equal to | 04-16-2009 |
Katarina Rot, Leonding AT
Patent application number | Description | Published |
---|---|---|
20120277429 | Melamine Based Mannich-Compounds and a Process for Obtaining the Same - The present invention relates to Melamine based Mannich compounds of the general formulae (1)-(12) and a process for synthesizing melamine based Mannich-products comprising the steps of a) reacting at least one substituted melamine with at least one aldehyde, in particular formaldehyde, under basic conditions to form at least one OH-containing compound, b) reacting the at least one OH-containing compound in the presence of a catalyst to form at least one mannich-base, c1) reacting the at least one mannich-base with at least one enol-forming carbonyl compound, or c2) reacting the at least one mannich-base with at least one aromatic compound, and d) working up the reaction mixture. The invention relates further to precondensates obtainable from these products. | 11-01-2012 |
20120329906 | Use of Modified Inorganic Particles as Aldehyde Scavenger and Curing Agent, in Particular in Wood Based Panels - The present invention relates to the use of at least one inorganic particle having a layered structure and being modified by cation exchange, in particular as a functional additive, as an aldehyde scavenger, in particular as a formaldehyde scavenger, as a curing agent and for improving properties of WBPs, in particular particle boards. The invention relates further to a composition comprising said particles. | 12-27-2012 |
Katarina Tengvall, Upplands Vasby SE
Patent application number | Description | Published |
---|---|---|
20150376702 | METHODS FOR ASSESSING THE RISK OF CANINE ATOPIC DERMATITIS - The present invention relates to methods for assessing the risk of a dog to develop canine atopic dermatitis. The methods comprise detecting in a sample of DNA obtained from a dog the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on dog ( | 12-31-2015 |
Katarina Tomanová, Puchov SK
Patent application number | Description | Published |
---|---|---|
20140039096 | BIOLOGICALLY DEGRADABLE POLYMERIC COMPOSITION WITH HIGH DEFORMABILITY - The invention concerns a biologically degradable polymeric composition containing 5 to 95 wt % of polyhy droxyalkanoate and 95 to 5 wt % of polylactic acid or lactide with addition of 2 to 67 parts of plasticizer or mixture of plasticizers per 100 parts of the polymeric blend. The invention covers also composition containing 0.05 to 5 wt % of a reactive additive. Plasticizers are selected from chemicals, such as esters of citric acid, esters of glycerol, esters of phosphoric acid, esters of sebacic acid and other liquid organic low-molecular polyesters. The reactive additive is selected from a group of chemicals such as acrylic polymers, epoxidized acrylic polymers, diisocyanates and their derivatives, epoxidized oils, oligomeric copolymers of various monomers with glycidyl methacrylate and other species. | 02-06-2014 |
Katarina Vrublova, Banska Bystrica SK
Patent application number | Description | Published |
---|---|---|
20090197305 | PROCESS FOR THE PREPARATION OF POLYMYXIN B EMPLOYING (PAENI) BACILLUS POLYMYXA - The invention is related to the process of fermentation with production strain | 08-06-2009 |
Katarina Vulic, Oakville CA
Patent application number | Description | Published |
---|---|---|
20140187487 | AFFINITY-BASED CONTROLLED RELEASE SYSTEM - Prolonged or extended release of bioactive protein is achieved using an affinity-based approach which exploits the specific binding of Src homology 3 (SH3) domain with short proline-rich peptides. Specifically, methylcellulose was modified with SH3-binding peptides (MC-peptide) with either a weak affinity or strong affinity for SH3. Controlled release of chondroitinase ABC (ChABC) is also described. | 07-03-2014 |